Young 'bucket list' girl with Hodgkin's recognized with award
The young girl with Hodgkin's lymphoma from the United Kingdom who this past summer became an international sensation on social media sites after she published her 'bucket list' online has been named the UK's most inspirational young woman.
Alice Pyne, the 15 year old from south Cumbria, won her category at the Inspiration Awards for Women at Cadogan Hall, hosted by former GMTV presenter Andrew Castle and Sky News anchor Sarah-Jane Mee. The awards were created to celebrate women from diverse backgrounds who have inspired the country. Pyne herself was being recognized largely for her international campaign to encourage others to join the bone marrow registry.
Pyne beat out some serious competition in being given the award, including the likes of Harry Potter star Emma Watson, Victoria Beckham and singer Lady Gaga.
Alice's 12 year old sister Milly was also named the winner of her category, that of Most Inspirational Fundraiser , after raising more than £100,000, most of it going towards the Great Ormond Street Hospital.
The awards' founder also announced a special inspiration award for the work done by the entire family .
Source: NW Evening Mail
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
